Discontinuation report MYLAN-BUPRENORPHINE/NALOXONE

Last updated on 2019-09-18 History
Report ID 94048
Drug Identification Number 02408104
Brand name MYLAN-BUPRENORPHINE/NALOXONE
Common or Proper name BUPRENORPHINE/NALOXONE
Company Name MYLAN PHARMACEUTICALS ULC
Active Ingredient(s) BUPRENORPHINE NALOXONE
Strength(s) 8MG 2MG
Dosage form(s) TABLET
Route of administration SUBLINGUAL
Packaging size 100BT
ATC code N07BC
ATC description DRUGS USED IN ADDICTIVE DISORDERS
Reason for discontinuation Business reasons
Anticipated discontinuation date 2019-09-17
Actual discontinuation date 2019-09-17
Remaining supply date 2019-09-17
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments Discontinued in Shortage ID 3089. Last lot 3085363 exp 2019-05-31
Health Canada comments
Contact Address 85 ADVANCE ROAD
ETOBICOKE, ONTARIO
CANADA M8Z 2S6
Company contact information Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v3 2019-09-18 English Compare
v2 2019-09-17 French Compare
v1 2019-09-17 English Compare